AtaiBeckley (ATAI) EBT (2020 - 2026)
AtaiBeckley (ATAI) recorded quarterly EBT of -$29.8 million in Q1 2026, down 13.2% quarter-over-quarter from -$26.3 million in Q1 2025, and down 13.2% on a YoY basis from -$34.3 million in Q1 2025.
AtaiBeckley (ATAI) EBT (2020 - 2026) Analysis & Trends
AtaiBeckley has disclosed EBT across 6 years of filings, most recently posting -$61.0 million for Q3 2025.
- EBT for Q3 2025 came in at -$61.0 million, down 130.39% year-over-year; the trailing twelve-month figure through Sep 2025 was -$154.1 million (down 20.83% YoY), and the FY2024 annual result was -$148.4 million, down 277.76% from the prior year.
- EBT was -$29.8 million for Q1 2026 at AtaiBeckley, down from -$26.3 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$26.3 million in Q1 2025 to a low of -$29.8 million in Q1 2026.
- The 5-year median for EBT is -$31.7 million (2023), against an average of -$30.2 million.
- Across the five-year window, EBT sank 841.8% in 2021 and jumped 232.33% in 2023, its largest moves.
- AtaiBeckley's EBT stood at -$48.6 million in 2021, then increased by 19.06% to -$39.3 million in 2022, then jumped by 53.41% to -$18.3 million in 2023, then tumbled by 113.89% to -$39.2 million in 2024, then sank by 55.59% to -$61.0 million in 2025.
- The last three EBT figures came in at -$61.0 million (Q3 2025), -$27.7 million (Q2 2025), and -$26.3 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | -29.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.78 Mn |
| Sep 30, 2025 | -60.97 Mn |
| Jun 30, 2025 | -27.65 Mn |
| Mar 31, 2025 | -26.31 Mn |
| Mar 31, 2025 | -26.31 Mn |
| Dec 31, 2024 | -39.18 Mn |
| Sep 30, 2024 | -26.46 Mn |
| Jun 30, 2024 | -57.08 Mn |
| Mar 31, 2024 | -25.68 Mn |
| Dec 31, 2023 | -18.32 Mn |
| Sep 30, 2023 | 43.85 Mn |
| Jun 30, 2023 | -31.66 Mn |
| Mar 31, 2023 | -33.16 Mn |
| Dec 31, 2022 | -39.32 Mn |
| Sep 30, 2022 | -33.13 Mn |
| Jun 30, 2022 | -30.81 Mn |
| Mar 31, 2022 | -31.92 Mn |
| Dec 31, 2021 | -48.58 Mn |
| Sep 30, 2021 | -26.47 Mn |
| Jun 30, 2021 | -67.30 Mn |